Why the Fluence (ASX:FLC) share price is up 10% today

The Fluence Corporation Ltd (ASX: FLC) share price is surging higher today, putting it at the top of the All Ords big gainers' board. Here's why.

| More on:

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

The Fluence Corporation Ltd (ASX: FLC) share price is up 10% in late afternoon trading. That puts the company in the enviable position of being among the biggest gains posted on the All Ordinaries Index (ASX: XAO) today, with the All Ords down 1.8%.

The share price surge comes following today's update on the company's Ivory Coast water treatment project. And it will come as welcome news to shareholders who've watched the share price slide for much of the year.

With today's gains, the Fluence share price is down 50% year-to-date. That compares to a 10% loss for the All Ords.

Rising share price chart.

Image source: Getty Images

What does Fluence do?

Fluence is involved in the decentralised water, wastewater and reuse treatment markets. Its smart products solutions include Aspira, NIROBO and SUBRE. The company's range of services range from early stage evaluation to design and delivery through to ongoing support and optimisation of water related assets. Fluence operates in 70 countries, with established operations in North America, South America, the Middle East, Europe and China. It aims to help businesses and communities make the most of their water resources.

Why did the Fluence share price leap higher?

Fluence announced that the Israel Discount Bank had confirmed the final conditions precedent for the 165 million euro (AU$275 million) Ivory Coast water treatment plant. The Ivory Coast finance facility will now begin funding contractual payments to Fluence for the plant.

Fluence plans to start construction immediately. The surface water treatment plant will be capable of treating 150,000 cubic metres of water daily. It will treat contaminated water from Lagune Aghein, the biggest freshwater reserve in Ivory Coast, helping to supply fresh water to Abidjan, the nation's most populous city.

Commenting on the news, Fluence CEO Henry Charrabe said:

Despite challenging logistics and COVID-19 related delays, we are very pleased to have been able to meet this key milestone to progress the Ivory Coast Project and to officially commence construction. This is an immensely important project for the people of Ivory Coast, and we look forward to now fully mobilising.

Motley Fool contributor Bernd Struben has no position in any of the stocks mentioned. The Motley Fool Australia has no position in any of the stocks mentioned. We Fools may not all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

More on Share Market News

A white EV car and an electric vehicle pump with green highlighted swirls representing ASX lithium shares
Broker Notes

Up 473% in a year, should I buy PLS shares today?

PLS – formerly Pilbara Minerals – leads the ASX 200’s top one-year gains board. But can the ASX lithium stock…

Read more »

Researchers and doctors with futuristic 3D hologram overlay for body anatomy or DNA in hospital clinic.
Broker Notes

Why 4DMedical shares can return to record highs: Expert

Why it could be an ideal time to buy the dip on this exciting stock.

Read more »

Top ten gold trophy.
Share Gainers

Here are the top 10 ASX 200 shares today

Investors weren't in a good mood this Tuesday.

Read more »

A child covering his eyes hiding from a toy bear.
Broker Notes

Brokers rate these 5 ASX 200 shares as a sell!

Find out why brokers are so bearish about these ASX 200 shares.

Read more »

a woman looks exhausted and overwhelmed as she slumps forward into her hand while looking at her laptop screen.
52-Week Lows

Are CSL and ResMed shares buys at 52-week lows?

These ASX healthcare shares may not regain investor confidence overnight, but I think they are worth studying while sentiment is…

Read more »

a man weraing a suit sits nervously at his laptop computer biting into his clenched hand with nerves, and perhaps fear.
Share Fallers

WiseTech, Cochlear, CSL shares: Can these beaten down stocks rebound in 2026?

It looks like brokers have lost confidence in one of these shares.

Read more »

A woman looks at a tablet device while in the aisles of a hardware style store amid stacked boxes on shelves representing Bunnings and the Wesfarmers share price
Broker Notes

Wesfarmers shares: Buy, hold or sell?

Two leading analysts offer their outlooks for Wesfarmers shares.

Read more »

A young woman raises her hands in joyful celebration as she sits at her computer in a home environment.
52-Week Highs

3 top ASX shares at 52-week highs I'd still buy

A 52-week high should not automatically scare investors away if the business still has room to improve over time.

Read more »